Efficacy of enzalutamide (ENZA) + androgen deprivation therapy (ADT) in metastatic hormone-sensitive prostate cancer (mHSPC) by pattern of metastatic spread: ARCHES post hoc analyses.

Authors:

Shore N, Armstrong A, Szmulewitz R, et al.

Year

2020

Conference

ASCO Annual Meeting

Start Date

May 29

End Date

Jun 2